Chronic myeloid leukemia ( CML ) results when the growth of white blood cells goes berserk and too many are produced in the bone marrow. A new method to treat this disease is being studied.

The Oncologic Drugs Advisory Committee ( ODAC ) to the U.S. Food and Drug Administration (FDA) has voted unanimously to recommend that the FDA grant accelerated approval of Adcetris ( brentuximab vedotin ).

Acute lymphoblastic leukemia is the most common type of childhood cancer. A new drug therapy holds promise in treating this particularly aggressive disease.

Acute lymphoblastic leukemia (ALL) used to be one of the deadliest cancers for children and young adults. Now it's one of the most curable, and cures rates are climbing.

If we only knew exactly what caused Alzheimer's disease, it might be easier to treat. Scientists are making headway in both arenas. 

The majority of patients with chronic myeloid leukemia recover using various cancer drug treatments. However, they are not cured, as a type of cancerous stem cell is resistant to the drugs.

Researchers have gained new insights into one of the most aggressive tumors affecting humans, Burkitt's lymphoma cancer. There may be new ways of treating this painful and deadly disease with a new mechanism responsible for breaking down the genetic protections against tumors.

A team of University of Wisconsin-Madison researchers has successfully completed the first reprogramming of blood cells obtained from a patient with leukemia.

Children vaccinated against hepatitis B might be at a lower risk of developing leukemia, according to a new study.

Follicular lymphoma patients fare better after receiving two years of rituximab-maintenance therapy following immunochemotherapy, according to a new study.